We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,306.00
Bid: 2,306.00
Ask: 2,308.00
Change: -33.00 (-1.41%)
Spread: 2.00 (0.09%)
Open: 2,325.00
High: 2,393.00
Low: 2,306.00
Yest. Close: 2,339.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

London open: Stocks bounce even as analysts warn on emerging markets

(ShareCast News) - The selling pressure on stocks abated as investors waited on the US Federal Reserve's policy announcement on Wednesday, but worries regarding the outlook for China, Greece and the possibility of interest rate increases were still very much on investors' minds. As of 08:47 the FTSE

28 Jul 15 09:42

LONDON MARKET MID-MORNING: Pound Surges After UK GDP Comes In-Line

28 Jul 15 09:41

WINNERS & LOSERS SUMMARY: Zurich Interest Sends RSA Insurance Higher

28 Jul 15 09:12

Hikma Pharmaceuticals acquires US labs in $2.25bn deal

(ShareCast News) - Drug developer Hikma Pharmaceuticals signed a deal to buy two firms from Boehringer Ingelheim in transactions worth a total of $2.25bn. FTSE 100 listed Hikma planned to buy Roxane Laboratories and associated company Boehringer Ingelheim Roxane in a cash and shares deal that would

28 Jul 15 08:28

BUZZ-Hikma: best day in 7 months after announcing Boehringer deal

** Hikma rises 6.7 pct after agreeing to buy Boehringer's specialty generics business for $2.65 bln in cash ** Valuation based on new Hikma shares priced at £23.50 ** Best day for stock since January 2015 ** Among top risers and most traded by average volumes on Stoxx 600 <p

28 Jul 15 07:33

LONDON BRIEFING: Royal Mail Shares Hit By Ofcom Accusation

28 Jul 15 07:31

UPDATE 1-Hikma to buy Boehringer's U.S. generics unit for $2.65 bln

(Adds details) July 28 (Reuters) - Hikma Pharmaceuticals Plc said it would buy German drugmaker Boehringer Ingelheim's U.S. specialty generic drugs business for about $2.65 billion in cash and stock to bolster its presence in the United States. Hikma said it will pay about $1.18 billi

28 Jul 15 07:23

Hikma to buy Boehringer's U.S. generics unit for $2.65 bln

July 28 (Reuters) - Hikma Pharmaceuticals Plc said it would buy German drugmaker Boehringer Ingelheim's U.S. specialty generic drugs business for about $2.65 billion in cash and stock to bolster its presence in the United States. Hikma said it will pay about $1.18 billion in cash and issue

28 Jul 15 06:34

Hikma Pharmaceuticals To Acquire Roxane Units For USD2.65 Billion (ALLISS)

28 Jul 15 06:32

LONDON MARKET CLOSE: Stocks Mixed Amid Puzzling Greek Offer Exchange

30 Jun 15 15:56

WINNERS & LOSERS: Tesco And Sainsbury's Beaten By Morrisons

30 Jun 15 10:17

TOP NEWS: UK Economic Growth Revised Up In First Quarter

30 Jun 15 10:09

LONDON BRIEFING: Shares Ignore Positive Asian Session To Open Lower

30 Jun 15 07:31

PRESS: Hikma, Mallinckrodt Bid For Boehringer Assets - Bloomberg

30 Jun 15 05:18

Boehringer's Roxane Labs draws bid from Hikma, Mallinckrodt- Bloomberg

June 29 (Reuters) - Jordan's Hikma Pharmaceuticals Plc has emerged as a bidder for German drugmaker Boehringer Ingelheim's generics unit Roxane Labs, Bloomberg reported, citing people familiar with the matter. Other bidders for the U.S.-based Boehringer unit include Mallinckrodt Plc and Pe

29 Jun 15 22:37

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.